| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Genedx Holdings Corp. (WGS) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 36 sells. WGS is classified in the Life Sciences Tools & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 3.01M | $166.66M | - | |
| Dir | 114.7K | $6.36M | - | |
| CEO | 93.8K | $5.20M | - | |
| CFO | 12.6K | $697.5K | - | |
| ? | 12.0K | $665.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 9, 2024 | Feeley Kevin47 | Chief Financial Officer | Sale+OE | 1,137 | $76.37 | $86,835.87 | -4.4% | +23.1% | +120.7% | |
| Dec 2, 2024 | Feeley Kevin47 | Chief Financial Officer | Sale+OE | 263 | $78.39 | $20,616.89 | -1.1% | +22.2% | +107.9% | |
| Nov 22, 2024 | Feeley Kevin47 | Chief Financial Officer | Sell | 22,000 | $74.81 | $1,645,810.27 | -6.4% | +29.1% | +86.2% | |
| Nov 20, 2024 | Ryan Jason65 | Director | Sell | 47,000 | $70.57 | $3,316,879.80 | -36.1% | +62.5% | +93.3% | |
| Nov 18, 2024 | Icahn School Of Medicine At Mount Sinai | 10% Owner | Sell | 147,141 | $70.64 | $10,393,722.68 | -2.6% | +58.6% | +78.5% | |
| Nov 18, 2024 | Stueland Katherine | Chief Executive Officer | Sell | 45,415 | $70.41 | $3,197,684.33 | -4.1% | +58.6% | +78.5% | |
| Oct 31, 2024 | Icahn School Of Medicine At Mount Sinai | 10% Owner | Sell | 865,800 | $75.00 | $64,935,000.00 | -23.2% | -7.4% | +67.6% | |
| Oct 29, 2024 | Feeley Kevin47 | Chief Financial Officer | Sale+OE | 274 | $66.60 | $18,248.40 | -0.6% | -10.9% | +56.8% | |
| Oct 29, 2024 | Stueland Katherine | Chief Executive Officer | Sale+OE | 2,154 | $66.60 | $143,456.40 | -2.0% | -10.9% | +56.8% | |
| Sep 16, 2024 | Stueland Katherine | Chief Executive Officer | Sale+OE | 10,501 | $37.59 | $394,732.59 | -9.2% | +113.4% | +221.8% |